TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.42%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| 1 |
Apple
AAPL
|
+$257M |
| 2 |
UnitedHealth
UNH
|
+$226M |
| 3 |
Colgate-Palmolive
CL
|
+$217M |
| 4 |
Moody's
MCO
|
+$203M |
| 5 |
Curtiss-Wright
CW
|
+$189M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$744M |
| 2 |
Lam Research
LRCX
|
+$339M |
| 3 |
Merck
MRK
|
+$305M |
| 4 |
Vistra
VST
|
+$200M |
| 5 |
ConocoPhillips
COP
|
+$181M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Hawkins
HWKN
$3.56B
| $2.8M | ﹤0.01% |
22,300
+2,000
| +10% | +$251K |
|
|
IGMS
927
DELISTED
IGM Biosciences
IGMS
| $2.8M | ﹤0.01% |
164,472
| – | – |
|
928
Geron
GERN
$823M
| $2.77M | ﹤0.01% |
606,214
-594,986
| -50% | -$2.72M |
|
929
Charles River Laboratories
CRL
$7.54B
| $2.76M | ﹤0.01% |
13,927
-96,502
| -87% | -$19.1M |
|
930
Papa John's
PZZA
$1.63B
| $2.76M | ﹤0.01% |
52,046
+5,600
| +12% | +$296K |
|
931
FTI Consulting
FCN
$5.23B
| $2.73M | ﹤0.01% |
12,100
+3,200
| +36% | +$721K |
|
932
Owens Corning
OC
$12.8B
| $2.72M | ﹤0.01% |
15,618
-57
| -0.4% | -$9.94K |
|
933
Energy Fuels
UUUU
$2.91B
| $2.72M | ﹤0.01% |
489,554
+51,815
| +12% | +$287K |
|
934
Solventum
SOLV
$12.3B
| $2.71M | ﹤0.01% |
40,144
-27,847
| -41% | -$1.88M |
|
935
Installed Building Products
IBP
$7.21B
| $2.71M | ﹤0.01% |
10,814
-10,600
| -50% | -$2.65M |
|
936
Prestige Consumer Healthcare
PBH
$3.2B
| $2.7M | ﹤0.01% |
37,900
-8,200
| -18% | -$585K |
|
937
Qorvo
QRVO
$8.26B
| $2.7M | ﹤0.01% |
26,057
-544
| -2% | -$56.4K |
|
938
CG Oncology
CGON
$2.56B
| $2.68M | ﹤0.01% |
70,836
-22,248
| -24% | -$843K |
|
939
Generac Holdings
GNRC
$10.9B
| $2.68M | ﹤0.01% |
17,286
+5,808
| +51% | +$899K |
|
940
Crane Co
CR
$10.5B
| $2.67M | ﹤0.01% |
16,994
-200
| -1% | -$31.5K |
|
|
CNH
941
CNH Industrial
CNH
$14.1B
| $2.66M | ﹤0.01% |
235,067
+23,205
| +11% | +$263K |
|
942
Innospec
IOSP
$2.06B
| $2.66M | ﹤0.01% |
23,300
+6,300
| +37% | +$719K |
|
943
Matsons
MATX
$3.28B
| $2.64M | ﹤0.01% |
18,600
+7,000
| +60% | +$994K |
|
944
Badger Meter
BMI
$5.23B
| $2.64M | ﹤0.01% |
12,200
-7,300
| -37% | -$1.58M |
|
945
Cavco Industries
CVCO
$4.28B
| $2.63M | ﹤0.01% |
6,100
| – | – |
|
946
H.B. Fuller
FUL
$3.33B
| $2.62M | ﹤0.01% |
32,686
+4,520
| +16% | +$362K |
|
|
BCAX
947
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $2.61M | ﹤0.01% |
+102,420
| New | +$2.61M |
|
|
WBA
948
DELISTED
Walgreens Boots Alliance
WBA
| $2.59M | ﹤0.01% |
286,228
-92,801
| -24% | -$841K |
|
949
Dayforce
DAY
$10.9B
| $2.58M | ﹤0.01% |
42,856
+224
| +0.5% | +$13.5K |
|
950
Commault Systems
CVLT
$7.84B
| $2.57M | ﹤0.01% |
16,900
-400
| -2% | -$60.7K |
|